MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • MDS Virtual Congress 2020

    Wearable sensor monitoring in denovo Parkinson’s disease using the Parkinson’s KinetiGraph: pilot data and correlations from the MoNS-PD cohort

    N. Titova, D. Trivedi, Y. Bezdolny, E. Katunina, K. Ray Chaudhuri (Moscow, Russian Federation)

    Objective: To describe Parkinson’s kinetograph utilised clinical parameters and correlations in a denovo Parkison’s disease (PD) cohort from Moscow Russia. Background: The Parkinson’s KinetiGraph™ (PKG)…
  • MDS Virtual Congress 2020

    Kinematic assessment of bradykinesia in essential tremor compared to Parkinson’s disease: a cluster analysis

    M. Bologna, G. Paparella, D. Colella, A. Cannavacciuolo, L. Angelini, D. Alunni-Fegatelli, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: We aimed to evaluate the bradykinesia features in ET by clinical examination and kinematic analysis of repetitive finger movements. We compared data collected in…
  • MDS Virtual Congress 2020

    Motor onset of Parkinsonʼs disease: Is there a somatotopic pattern?

    M. Monje, A. Sánchez-Ferro, L. Vela-Desojo, F. Alonso-Frech, M. Di Leone, J. Pineda-Pardo, G. Foffani, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To study the clinical onset and progression of motor manifestations in different body regions in early PD patients. Background: The vulnerability of the nigrostriatal…
  • MDS Virtual Congress 2020

    Quantifying movement to measure Parkinson’s Disease severity and progression in a Phase 2 Study (SPARK)

    K.P Kilambi, S. Khan, J. Osik, T. Herrero, J. Edgerton, K. Erb, K. Hallock, M. Brys, M. Yang, J. Xiao, I. Sapir, T. Fox, P. Bergethon (Cambridge, MA, USA)

    Objective: To develop and evaluate objective measures of Parkinson’s disease (PD) severity and progression by applying dynamical systems analysis to inertial sensor kinematic data. Background:…
  • MDS Virtual Congress 2020

    Application of PKG System for Objective Measurement and Early Identification in Parkinson’s Disease

    C. Lina, C. Guoen, W. Huidan, W. Yingqing, C. Ying, C. Xiaochun, Y. Qinyong (Fuzhou, China)

    Objective: This study aimed to assess the correlations of the PKG data with clinical scores of bradykinesia, rigidity and tremor. Background: The treatment of levodopa…
  • MDS Virtual Congress 2020

    Passive monitored daily motor behavior significantly relates to quality of life in early Parkinson’s disease

    A. Thomann, K. Taylor, F. Lipsmeier, E. Volkova-Volkmar, R. Postuma, W.Y Cheng, B. van Lier, D. Trundell, W. Zago, A. Boulay, G. Pagano, C. Gossens, M. Lindemann (Basel, Switzerland)

    Objective: To investigate whether passively acquired measures of gait and hand gestures are associated with health-related quality of life (HrQoL; PDQ-39) and health-state (EQ-5D-5L) in…
  • MDS Virtual Congress 2020

    Improving estimation of Parkinson’s disease risk – enhancing the PREDICT-PD algorithm

    J. Bestwick, S. Auger, D. Grosset, S. Kanavou, G. Giovannoni, A. Lees, J. Cuzick, C. Simonet, R. Rees, D. Rack, M. Jitlal, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To develop and test an enhanced algorithm for the prediction of Parkinson’s disease (PD) risk. Background: The PREDICT-PD algorithm estimates risk of PD using…
  • MDS Virtual Congress 2020

    Ceftriaxone improves motor function in a rat hemi-parkinsonian model: Potential to delay bilateral progression of motor deficits in Parkinson’s disease

    E. Kasanga, C. McElroy, M. Salvatore (Fort Worth, TX, USA)

    Objective: This study sought to evaluate the impact of ceftriaxone, as a potential repurposed drug, in ameliorating motor decline in a unilateral rat 6-hydroxydopamine (6-OHDA)…
  • MDS Virtual Congress 2020

    Emerging motor dysfunction in those at-risk of Parkinson’s disease: 5-year follow-up of PREDICT-PD participants

    C. Simonet, A. Schrag, J. Bestwick, A. Lees, A. Noyce (London, United Kingdom)

    Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…
  • MDS Virtual Congress 2020

    Personal Kinetigraph and Deep Brain Stimulation with Parkinson’s Disease

    A. Potter, G. Newsome, G. Kern, A. Parsons, D. Page, Y. Dalati, C. Sidiropoulos MD (East Lansing, MI, USA)

    Objective: To better understand the utility of a wearable wrist sensor in assessing and managing motor fluctuations in a population of patients with advanced Parkinson…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley